Trials / Unknown
UnknownNCT01414530
Oral Contraceptive During Menopausal Transition
Effects of Oral Contraceptive on Muscle or Joint Ache in Women During Menopausal Transition
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- 45 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Muscle or joint pain is one of the most common symptoms during menopausal transition. As this could be severe enough to affect social and daily life and to reduce quality of life, attentions should be paid about this. Although understanding of muscle or joint pain related to menopause is still insufficient, estrogen can play an important role. Previous studies have shown that estrogen protects cartilage in both animals and humans. However, perimenopause is different from postmenopause, in the point that estrogen is still secreted with a great fluctuation. Until now, no study has been performed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition. Moreover, since menopausal symptoms vary according to ethnicity and culture, a study in Korean population is necessary. Therefore, this randomized controlled trial was designed to evaluate the effects of oral contraceptive on muscle or joint pain in women during menopausal transition, compared to NSAID (non-steroidal anti-inflammatory drug).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral contraceptive | ethinyl estradiol 0.03mg/levonorgestrel 0.15mg daily for 8 weeks |
| DRUG | NSAID | ibuprofen 200mg/arginine 185mg twice per day for 8 weeks |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2014-06-01
- First posted
- 2011-08-11
- Last updated
- 2013-09-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01414530. Inclusion in this directory is not an endorsement.